Lipid Controls
Avanti Polar Lipids Cholesterol (plant) Powder | 57-88-5 | 200mg
Cholesterol (plant) Powder | Purity: 99% | 57-88-5 | 200mg
Avanti Polar Lipids 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(6-azidohexanoyl) (ammonium salt), 2252461-34-8, 25 mg
Formula Weight: 848.145, Purity >99%, Storage Temperature: -20°C. This reagent is a modified lipid containing an omega-terminal azide. The terminal azide group can be used in a highly specific linking reaction with alkyne-containing reagents, known as ‘click chemistry’, in the presence of a copper (Cu)-containing catalyst.
LIPOID LLC PHOSAL 53 MCT, liquid, water-free concentrate, 1 kg
PHOSAL 53 MCT, liquid, water-free concentrate, 1 kg
Medchemexpress LLC D-Lin-MC3-DMA | 1224606-06-7 | MFCD31657426 | 50 mg
D-Lin-MC3-DMA | Purity: ≥98.0% | Mol Wt: 642.102 | 1224606-06-7 | MFCD31657426 | 50 mg
Avanti Polar Lipids TOPFLUOR CHOLESTEROL, 1MG
23-(dipyrrometheneboron difluoride)-24-norcholesterol (TopFluor Cholesterol). 878557-19-8
Medchemexpress LLC Dspe-peg2000-crgdkgpdc (disulfide bridge:Cys1-Cys9) | 95.0% | 2000 (Average) | 25 MG
DSPE-PEG2000-iRGD is a PEG compound composed of DSPE and an αv-integrins targeting peptide (iRGD). The iRGD peptide binds to αv-integrins and is then proteolytically cleaved in the tumor to produce CRGDK/R, which interacts with neuropilin-1. This compound has tumor-targeting and tumor-penetrating properties and can be used for agent delivery.
- Irgd peptide binds to αv-integrins.
- Proteolytically cleaved in the tumor to produce CRGDK/R to interact with neuropilin-1.
- Possesses tumor-targeting and tumor-penetrating properties.
- Can be used for agent delivery.
- Used to construct nanomicelles for targeted delivery of salinomycin to intervene in liver cancer cells and cancer stem cells.
- Used to construct a tumor-penetrating peptide liposome that exhibits antitumor effects, including a significant reduction in tumor volume and an increase in body weight and spleen index.
Cayman Chemical 1 3DIstearoyl2oloyl Glyce 50mg
A triacylglycerol; has been found in Kpangnana, Chinese tallow, and cocoa butters; increases the phagocytic function of reticulo-endothelial cells in mice at 5 and 10 mg per animal
![Medchemexpress LLC Poly(oxy-1,2-ethanediyl), α-[(9R)-6-hydroxy-6-oxido-1,12-dioxo-9-[(1-oxooctadecyl)oxy]- | 1445832-74-5 | 99.95% | 2000 (Average) | 25 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000385579-logo.png-250.jpg){kind=logo}
Medchemexpress LLC Poly(oxy-1,2-ethanediyl), α-[(9R)-6-hydroxy-6-oxido-1,12-dioxo-9-[(1-oxooctadecyl)oxy]- | 1445832-74-5 | 99.95% | 2000 (Average) | 25 MG
DSPE-PEG (2000)-COOH is a pegylated derivative of 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine. This compound is capable of forming micelles for targeted drug delivery.
- Can form micelles for targeted drug delivery
- Useful for polyvalent targeted delivery of vinorelbine to cancer cells
- Can be used as optical coherence tomography contrast agents for tumor angiography in live animals
- Targets liposome
- Pathway: Metabolic enzyme/protease
- Powder stable at -20°C for 3 years
- In solvent stable at -80°C for 6 months, and at -20°C for 1 month
- Solubility in H2O: 25 mg/mL (requires ultrasonic treatment)
- Solubility in DMSO: 25 mg/mL (requires ultrasonic, warming, and heating to 60°C)
- Achieves a clear solution at ≥ 2.5 mg/mL in specific in vivo solvent combinations
- For research use only
Cayman Chemical DLIn-KC2-DMA 1mg
An ionizable cationic lipid (pKa = 6.7); has been used in the formation of LNPs encapsulating siRNA or plasmid DNA for use in vitro and in vivo; LNPs containing DLin-KC2-DMA selectively accumulate in the liver after i.v. or i.m. administration in mice or localize to the retinal pigment epithelium and Müller glia after subretinal administration; DLin-KC2-DMA-containing LNPs encapsulating F7-targeted siRNA reduce serum Factor VII levels in mice; DLin-KC2-DMA-containing LNPs encapsulating AR-targeted siRNA decrease serum PSA and tumor androgen receptor levels in an LNCaP prostate cancer mouse xenograft model